MRM (MEDIROM Healthcare Technologies Inc. American Depositary Share) Stock Analysis - News
MEDIROM Healthcare Technologies Inc. American Depositary Share (MRM) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, MRM trades at $0.92 with a market cap of $7.62M and a P/E ratio of 0.00. MRM moved +4.97% today. Year to date, MRM is -52.07%; over the trailing twelve months it is -29.22%. Its 52-week range spans $0.34 to $5.30. Rallies surfaces MRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in MRM news today?
MEDIROM Partners with Tools for Humanity, Projects $39M Pre-Tax Income Over Two Years: MEDIROM Healthcare Technologies launched a Master Service Agreement with Tools for Humanity effective February 2, installing Orbs at over 150 Re.Ra.Ku locations. The company projects pre-tax income of approximately USD 39 million (JPY 6.10 billion) over two years if it expands Orb deployments to about 3,000 nationwide sites.
CRANE CO /DE/ bought 1.69M (~$27.09M) on Feb 3, 2010.
HAHN JAYSON sold 900 (~$8.29K) on Nov 19, 2009.
HAHN JAYSON sold 1.60K (~$14.72K) on Nov 19, 2009.
MRM Analyst Consensus
MRM analyst coverage data. Average price target: $0.00.
Common questions about MRM
What changed in MRM news today?
MEDIROM Partners with Tools for Humanity, Projects $39M Pre-Tax Income Over Two Years: MEDIROM Healthcare Technologies launched a Master Service Agreement with Tools for Humanity effective February 2, installing Orbs at over 150 Re.Ra.Ku locations. The company projects pre-tax income of approximately USD 39 million (JPY 6.10 billion) over two years if it expands Orb deployments to about 3,000 nationwide sites.
Does Rallies summarize MRM news?
Yes. Rallies summarizes MRM news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is MRM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRM. It does not provide personalized investment advice.
